Chrysea is building a platform that will deliver prevision, healthy lifespan nutritional intervention based on credible scientific evidence. Dr. Pedro de Noronha Pissarra, CEO of Chrysea, talks with Longevity Technology on lifespan intervention, the recent raise in a deal with Juvenescence and Banco Portugues Fomento and private investors, and its first product in the healthy lifespan field. "If they don't knock--well, then you build the door." Dr. de Noronha Pissarra
Read the full Longevity Technology article here.